One of the most highly cited medical scientists in the world, Mills brings a breadth of research, leadership experience to OHSU.

OHSU leads team to prevent cardiomyopathy through gene correction.

OHSU has been awarded two grants totaling $62 million from the National Center for Advancing Translational Sciences, to help bridge basic science and clinical research.

Expanding prenatal care to unauthorized immigrant women in Oregon reduced death rates for U.S. born infants and helped prevent disease and complications for both women and their children.

Researchers at Oregon Health & Science University are challenging the convention that tetanus and diphtheria vaccine boosters need to be administered every 10 years. Their paper in Clinical Infectious Diseases recommends that the current adult ...

The Oregon Clinical & Translational Research Institute at OHSU has received a $37 million boost from the federal government to help accelerate the translation of research into clinical use, medical practice and health policy.

A study published in the most recent version of the journal Obesity found that the body’s internal clock, the circadian system, increases hunger and cravings for sweet, starchy and salty foods in the evenings. While the urge to consume more in the ...

A collaboration with U.S. and Canadian-based networks of primary care practices, study will compare impacts of clinician-focused and team-based approaches to advance care planning.

A new Oregon Health & Science University and Portland Veterans Affairs Medical Center study suggests that early-stage Parkinson's disease patients who lower their calorie intake may boost levels of an essential brain chemical lost from the ...

Oregon Health & Science University today announced it met Nike co-founder Phil Knight and his wife Penny’s $1 billion challenge by raising $500 million in less than two years to earn the Knights’ matching gift and set a fundraising record.